NCT01444885 - Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Variant Angina

Interventions

DRUG

Placebo

2 weeks treatment of Cilostazol 100mg, or placebo oral tablets bid after 2 weeks treatment of Cilostazol 50mg, or placebo oral tablets bid (Total 4 weeks)

Trial Locations (10)

Unknown

Keimyung University Dongsan Medical Center, Daegu

ChungNam Univ. Hospital, Daejeon

Gangneung Asan Hospital, Gangneung

Chonnam National University Hospital, Gwangju

Gyongsang National University Hospital, Jinjoo

Dong-A University Hospital, Pusan

Pusan National University Yansan Hospital, Pusan

Asan Medical Center, Seoul

Ajou University Hospital, Suwon

Ulsan University Hospital, Ulsan